At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.
View Top Employees from RegeneronWebsite | http://www.regeneron.com |
Ticker | REGN |
Revenue | $8.32 billion |
Funding | $666.1 million |
Employees | 15,296 (14,502 on RocketReach) |
Founded | 1988 |
Address | 777 Old Saw Mill River Road, Tarrytown, New York 10591, US |
Phone | (914) 847-7000 |
Fax | (914) 347-2113 |
Technologies |
JavaScript,
HTML,
Twitter
+277 more
(view full list)
|
Industry | Biotechnology, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
Keywords | Biopharmaceuticals, Drug Development And Manufacturing, Biotechnology, Rare Disease, Pharmaceutical Commercialization |
Competitors | Alkermes, Amgen, Biogen, Ethypharm, Zentiva |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Regeneron employee's phone or email?
The Regeneron annual revenue was $8.32 billion in 2024.
David Glass is the Vice President Research of Regeneron.
14,502 people are employed at Regeneron.
Regeneron is based in Tarrytown, New York.
The NAICS codes for Regeneron are [32, 325, 3254, 32541].
The SIC codes for Regeneron are [28, 283].